» Articles » PMID: 25603463

Changes in Vertebral Bone Marrow Fat and Bone Mass After Gastric Bypass Surgery: A Pilot Study

Overview
Journal Bone
Date 2015 Jan 21
PMID 25603463
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Bone marrow fat may serve a metabolic role distinct from other fat depots, and it may be altered by metabolic conditions including diabetes. Caloric restriction paradoxically increases marrow fat in mice, and women with anorexia nervosa have high marrow fat. The longitudinal effect of weight loss on marrow fat in humans is unknown. We hypothesized that marrow fat increases after Roux-en-Y gastric bypass (RYGB) surgery, as total body fat decreases. In a pilot study of 11 morbidly obese women (6 diabetic, 5 nondiabetic), we measured vertebral marrow fat content (percentage fat fraction) before and 6 months after RYGB using magnetic resonance spectroscopy. Total body fat mass declined in all participants (mean ± SD decline 19.1 ± 6.1 kg or 36.5% ± 10.9%, p<0.001). Areal bone mineral density (BMD) decreased by 5.2% ± 3.5% and 4.1% ± 2.6% at the femoral neck and total hip, respectively, and volumetric BMD decreased at the spine by 7.4% ± 2.8% (p<0.001 for all). Effects of RYGB on marrow fat differed by diabetes status (adjusted p=0.04). There was little mean change in marrow fat in nondiabetic women (mean +0.9%, 95% CI -10.0 to +11.7%, p=0.84). In contrast, marrow fat decreased in diabetic women (-7.5%, 95% CI -15.2 to +0.1%, p=0.05). Changes in total body fat mass and marrow fat were inversely correlated among nondiabetic (r=-0.96, p=0.01) but not diabetic (r=0.52, p=0.29) participants. In conclusion, among those without diabetes, marrow fat is maintained on average after RYGB, despite dramatic declines in overall fat mass. Among those with diabetes, RYGB may reduce marrow fat. Thus, future studies of marrow fat should take diabetes status into account. Marrow fat may have unique metabolic behavior compared with other fat depots.

Citing Articles

Function and Regulation of Bone Marrow Adipose Tissue in Health and Disease: State of the Field and Clinical Considerations.

Zhang X, Tian L, Majumdar A, Scheller E Compr Physiol. 2024; 14(3):5521-5579.

PMID: 39109972 PMC: 11725182. DOI: 10.1002/cphy.c230016.


Bone marrow adipose tissue composition and glycemic improvements after gastric bypass surgery.

Kim T, Schwartz A, Li X, Xu K, Kazakia G, Grunfeld C Bone Rep. 2022; 17:101596.

PMID: 35734226 PMC: 9207612. DOI: 10.1016/j.bonr.2022.101596.


The dynamics of human bone marrow adipose tissue in response to feeding and fasting.

Fazeli P, Bredella M, Pachon-Pena G, Zhao W, Zhang X, Faje A JCI Insight. 2021; 6(12).

PMID: 33974568 PMC: 8262500. DOI: 10.1172/jci.insight.138636.


Impact of sleeve gastrectomy on bone outcomes in adolescents vs. adults with obesity.

Bredella M, Karzar N, Singhal V, Bose A, Animashaun A, Mitchell D Bone. 2021; 149:115975.

PMID: 33901724 PMC: 8217278. DOI: 10.1016/j.bone.2021.115975.


Zoledronic acid for prevention of bone loss in patients receiving bariatric surgery.

Liu Y, Cote M, Cheney M, Lindeman K, Rushin C, Hutter M Bone Rep. 2021; 14:100760.

PMID: 33816718 PMC: 8005765. DOI: 10.1016/j.bonr.2021.100760.


References
1.
Chao D, Espeland M, Farmer D, Register T, Lenchik L, Applegate W . Effect of voluntary weight loss on bone mineral density in older overweight women. J Am Geriatr Soc. 2000; 48(7):753-9. DOI: 10.1111/j.1532-5415.2000.tb04749.x. View

2.
Botolin S, McCabe L . Bone loss and increased bone adiposity in spontaneous and pharmacologically induced diabetic mice. Endocrinology. 2006; 148(1):198-205. DOI: 10.1210/en.2006-1006. View

3.
Shen W, Chen J, Punyanitya M, Shapses S, Heshka S, Heymsfield S . MRI-measured bone marrow adipose tissue is inversely related to DXA-measured bone mineral in Caucasian women. Osteoporos Int. 2006; 18(5):641-7. PMC: 2034514. DOI: 10.1007/s00198-006-0285-9. View

4.
Harris T, Launer L, Eiriksdottir G, Kjartansson O, Jonsson P, Sigurdsson G . Age, Gene/Environment Susceptibility-Reykjavik Study: multidisciplinary applied phenomics. Am J Epidemiol. 2007; 165(9):1076-87. PMC: 2723948. DOI: 10.1093/aje/kwk115. View

5.
Bolotin H . DXA in vivo BMD methodology: an erroneous and misleading research and clinical gauge of bone mineral status, bone fragility, and bone remodelling. Bone. 2007; 41(1):138-54. DOI: 10.1016/j.bone.2007.02.022. View